Unicompartmental Knee Arthroplasty Is Associated with a Lower Rate of Periprosthetic Joint Infection Compared to Total Knee Arthroplasty by Lee, Cody S. et al.
University of Kentucky 
UKnowledge 
Orthopaedic Surgery and Sports Medicine 
Faculty Publications Orthopaedic Surgery and Sports Medicine 
8-2021 
Unicompartmental Knee Arthroplasty Is Associated with a Lower 
Rate of Periprosthetic Joint Infection Compared to Total Knee 
Arthroplasty 
Cody S. Lee 
Univesity of Chicago 
Edwin P. Su 
Hospital for Special Surgery 
Michael B. Cross 
Hospital for Special Surgery 
Alberto V. Carli 
Hospital for Special Surgery 
David C. Landy 
University of Kentucky, David.Landy@uky.edu 
See next page for additional authors 
Follow this and additional works at: https://uknowledge.uky.edu/orthopaedicsurgery_facpub 
 Part of the Orthopedics Commons 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Repository Citation 
Lee, Cody S.; Su, Edwin P.; Cross, Michael B.; Carli, Alberto V.; Landy, David C.; and Chalmers, Brian P., 
"Unicompartmental Knee Arthroplasty Is Associated with a Lower Rate of Periprosthetic Joint Infection 
Compared to Total Knee Arthroplasty" (2021). Orthopaedic Surgery and Sports Medicine Faculty 
Publications. 33. 
https://uknowledge.uky.edu/orthopaedicsurgery_facpub/33 
This Article is brought to you for free and open access by the Orthopaedic Surgery and Sports Medicine at 
UKnowledge. It has been accepted for inclusion in Orthopaedic Surgery and Sports Medicine Faculty Publications 
by an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. 
Unicompartmental Knee Arthroplasty Is Associated with a Lower Rate of 
Periprosthetic Joint Infection Compared to Total Knee Arthroplasty 
Digital Object Identifier (DOI) 
https://doi.org/10.1016/j.artd.2021.06.006 
Notes/Citation Information 
Published in Arthroplasty Today, v. 10. 
© 2021 The Authors 
This is an open access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-
nc-nd/4.0/). 
Authors 
Cody S. Lee, Edwin P. Su, Michael B. Cross, Alberto V. Carli, David C. Landy, and Brian P. Chalmers 
This article is available at UKnowledge: https://uknowledge.uky.edu/orthopaedicsurgery_facpub/33 
Original research
Unicompartmental Knee Arthroplasty Is Associated With a Lower Rate
of Periprosthetic Joint Infection Compared to Total Knee Arthroplasty
Cody S. Lee, MD b, Edwin P. Su, MD a, Michael B. Cross, MD a, Alberto V. Carli, MD a,
David C. Landy, MD, PhD c, Brian P. Chalmers, MD a, *
a Department of Orthopedic Surgery Adult Reconstruction and Joint Replacement, Hospital for Special Surgery, New York, NY
b Department of Orthopedic Surgery, Univesity of Chicago, Chicago, IL
c Department of Orthopedic Surgery, University of Kentucky, Lexington, KY
a r t i c l e i n f o
Article history:
Received 16 March 2021
Received in revised form
10 May 2021
Accepted 14 June 2021








a b s t r a c t
Background: Several studies have reported lower perioperative complications with unicompartmental
knee arthroplasty (UKA) than with total knee arthroplasty (TKA). However, there is a paucity of data
analyzing the incidence of periprosthetic joint infection (PJI) in similar patients undergoing UKA and
TKA. As such, we sought to analyze the incidence of UKA and TKA PJI in a large matched population.
Material and Methods: The Mariner data set of the PearlDiver database was queried for all patients
undergoing UKA or TKA during 2010-2017. Included patients were required to have at least 2 years of
database inclusion after surgery. Patients were then matched at a 1:3 ratio (UKA:TKA) on age, gender,
Elixhauser Comorbidity Index, tobacco use, and obesity. Rates of PJI requiring operative intervention
within 90 days and 1 year were calculated.
Results: In total, 5636 patients having undergone UKA were matched to 16,890 patients having under-
gone TKA. Fifteen (0.27%) after UKA and 79 (0.47%) after TKA had a PJI surgically managed within 90 days
(risk ratio ¼ 0.57, 95% confidence interval ¼ 0.33-0.99, P ¼ .04). Thirty (0.53%) after UKA and 136 (0.81%)
after TKA had a PJI surgically managed within 1 year (risk ratio ¼ 0.66, 95% confidence interval ¼ 0.45-
0.98, P ¼ .04).
Conclusions: In a large group of rigorously matched patients, UKA was associated with a significantly
lower rate of surgically managed PJI than TKA at 90 days and 1 year; however, the rate of PJI in both
groups remained low at <1% at 90 days and 1 year.
© 2021 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee
Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
Introduction
Unicompartmental knee arthroplasty (UKA) remains a suc-
cessful surgery to relieve pain and improve function in select pa-
tients with isolated compartment pathology [1-4]. While
traditionally the criteria for UKAwere strict [5], the indications and
criteria have expanded [2,6-9], and the incidence of UKA has
increased over the past decade [10,11]. Furthermore, the intro-
duction of robotic and computer-assisted techniques has been
shown to improve UKA alignment, component position, and
potentially functional outcomes and revision rates [12-14]; as such,
the wider adoption of robotic-assisted UKA may further increase
the incidence of UKA [14,15].
While the long-term revision rates of UKA are higher than those
of total knee arthroplasty (TKA) in most series in the literature
[4,16-18], there are several reported advantages of a UKA compared
with TKA. These include improvement in functional outcomes,
higher activity level, quicker recovery, less pain and narcotic re-
quirements postoperatively, and lower short-term complications
[17-24]. Furthermore, UKA has been touted to have a lower rate of
deep periprosthetic joint infection (PJI) than TKAs, although recent
data show that treatment of UKA PJIs does not have better out-
comes than TKA PJI treatment [25,26]. However, owing to the low
incidence of UKA compared with TKA [10,11], the relatively low
incidence of deep PJI in both UKA and TKA, and selection bias of
younger and healthier patients toward UKA [15-27], there is a
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paucity of adequately powered data comparing UKA and TKA PJI
rates in similar patient populations.
As such, the goal of the present study was to compare the
incidence of reoperation for deep PJI at 90 days and 1 year in a large
sample of patients from an administrative claims database under-
going UKA to a matched cohort of similar patients undergoing TKA.
In addition, we sought to analyze howUKA PJIs were treated at both
90 days and 1 year. We hypothesize that the rate of surgically




The Mariner data set of the PearlDiver research database
(PearlDiver Technologies, Colorado Springs, CO) was used to query
deidentified, administrative claims data from patients covered by
private insurance, Medicare Advantage, Medicaid, and/or claims
paid with cash. It includes roughly 122 million total patients and
spans the years of 2010 to 2018. The present study used Common
Procedural Terminology (CPT), International Classification of Dis-
eases (ICD)-9 and ICD-10 diagnosis and procedural codes included
within the data set (Appendix). The data within this database are
Health Insurance Portability and Accountability Act compliant and
deemed exempt from institutional review board review.
Patient selection and outcomes
Patients who underwent UKA and primary TKA were identified
using codes CPT-27,446 and CPT-27,447, respectively, to prelimi-
narily create 2 cohorts (Fig. 1). All patients were limited to analysis
of their first UKA or TKA if they underwent more than one UKA or
TKA in the database. Patients who were included in both groups,
with an index procedural code for TKA occurring after index UKA,
were included in the UKA cohort and eliminated from the TKA
cohort so that the patient could not be matched to himself/herself.
Patients were then limited to only those who had continuous
database inclusion for at least 2 years. In order to minimize po-
tential bias in patient selection criteria, patients with morbid
obesity (bodymass index [BMI] > 40 kg.m2) were excluded asmany
surgeons consider morbid obesity a contraindication for UKA. Pa-
tients in each cohort were then matched on a patient to patient
basis in a 1:3 ratio (UKA:TKA) on age, sex, Elixhauser Comorbidity
Index, obesity (BMI > 30 kg/m2), and tobacco use, and final de-
mographic information was reported for each matched cohort
(Table 1). Outcome of infection within 90 days and 1 year of index
procedure was reported for each cohort using ICD-9 and ICD-10
diagnosis codes for PJI (Table 2). In addition, the treatment mo-
dality used to address PJI in the UKA cohort was reported by
stratification into explantation or treatment with debridement,
antibiotics, and implant retention (DAIR) using CPT, ICD-9, and ICD-
10 procedural codes (Table 2). Diagnosis codes of PJI had to be
linked to the same record as the procedural code identified as the
mode of treatment.
Statistical analysis
Descriptive statistics were used to describe the demographic
and clinical characteristics of the matched groups. Descriptive
statistics were also used to present the rates of PJI at both 90 days
and 1 year in the UKA and TKA groups. The association between
surgical type and PJI at both 90 days and 1 year was expressed using
the relative risk of PJI in the UKA group compared with the TKA
group with 95% confidence intervals (C.I.) used to assess the sta-
tistical significance of this association. Even though there was
Figure 1. Flowchart representing the total number of patients in the database and those excluded due to inadequate follow-up or exclusion criteria. ECI, Elixhauser comorbidity
index.
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dependency structure within the data created by matching, this
could not be incorporated into the statistical analysis given the
manner in which data are output from the PearlDiver platform. We
elected to match 1:3 UKAs to TKAs given the rarity of UKA PJIs and
the significantly higher number of TKAs in the database. Descrip-
tive statistics were also used to describe the treatment character-
istics of UKA patients with PJI. No adjustment was made for
multiple hypothesis testing, and an alpha threshold of 0.05 was
used to assess the statistical significance of associations as reflected
by the 95% level for the C.I. All analyses were performed using Stata
16.1 (StataCorp, College Station, TX).
Results
Patient matching and demographics
In total, 5636 patients having undergone UKA were matched to
16,890 patients having undergone TKA (Table 1). As would be ex-
pected based on matching, the groups were evenly matched based
on demographic and clinical characteristics but not by service
location, which was not included in matching. Patients undergoing
UKA were more frequently treated as outpatient.
Incidence of PJI in UKA and TKA
Of patients undergoing UKA, 15 (0.27%) had a PJI surgically
managed within 90 days (Table 2). Of patients undergoing TKA, 79
(0.47%) had a PJI surgically managed within 90 days. UKA was
associated with a significantly lower risk of PJI within 90 days with
a risk ratio of 0.57 and 95% C.I. from 0.33 to 0.99 (P ¼ .04).
Of patients undergoing UKA, 30 (0.53%) had a PJI surgically
managed within 1 year. Of patients undergoing TKA, 136 (0.81%)
had a PJI surgically managed within 1 year. UKA was associated
with a statistically significant lower risk of PJI within 1 year, with a
risk ratio of 0.66 and 95% CI from 0.45 to 0.98 (P ¼ .04).
UKA PJI treatment
Of the 15 patients who underwent surgical management of their
UKA infection within 90 days, 10 (67%) initially underwent a DAIR.
Of the 15 patients who underwent surgical management of their
UKA between 91 days and 1 year of UKA, 6 (40%) initially under-
went a DAIR (Table 3).
Discussion
The overall incidence of UKA is steadily increasing and expected
to continue to increase in the next decade [6-11], especially with
the introduction of computer navigated and robotic techniques [12-
15]. Numerous studies have reported lower perioperative and
short-term complications of UKA compared to TKA [4,17-24]. The
low incidence of UKA compared to TKA and biased selection of
younger and potentially healthier patients for UKA over TKA render
such comparisons, especially for complications with a low inci-
dence such as PJI, and lead to studies being often underpowered
and biased. As such, we sought to rigorously match patients un-
dergoing UKA to those undergoing TKA in a large non-Medicare
population to compare the incidence of PJI in each cohort. We
found that UKA conferred a significantly lower rate of PJI than TKA
at 90 days (RR ¼ 0.57) and 1 year (RR ¼ 0.66).
Several studies have reported lower perioperative complication
rates of UKA, including lower medical complication rates [4,18],
reduced rates of venous thromboembolism [4,18], lower read-
mission rates [4,18], as well as decreased LOS, lower opioid re-
quirements, and improved functional outcomes [17,19,22]
compared with TKA. However, no studies to the authors’ knowl-
edge directly compare the incidence of UKA and TKA PJI in the US
population. Reported rates of UKA and TKA PJI vary significantly
depending on the institution and patient population, ranging from
0% to 2.5% [4,18-23,27,28e30] at early time points. Lum et al. [29]
reported a 0% UKA PJI rate in 650 patients with a BMI > 35 kg/m2 at
a mean follow-up of 2.3 years; conversely, Nettrour et al. [28] re-
ported a 2.2% rate of UKA PJI in patients with a BMI > 40 kg/m2 at a
mean follow-up of 3.4 years. While the reported rates of PJI vary,
most US cohort studies report the rate of UKA PJI from 0.5% to 1%
[4,27,28e30].
While there have been very few studies comparing UKA and
TKA PJI rates in the United States, a few studies of European pa-
tient populations have directly or indirectly compared their rates.
In a 1:3 matched cohort of 101,330 patients undergoing 25,334
UKAs and 75,996 TKAs in the National Joint Registry for England
and Wales analyzing adverse outcomes as a whole, Liddle et al.
[18] found a 2-fold increased risk of revision for UKA at 8 years but
Table 3
Surgical management of infection for UKA.
UKA, N ¼ 5636
PJI in 90 d
Explant 5 (33%)
DAIR 10 (67%)




Characteristics of matched UKA and TKA patients.
Characteristic UKA, N ¼ 5636 TKA, N ¼ 16,890
Sex
Male 2670 (47.4%) 7993 (47.3%)
Female 2966 (52.6%) 8897 (52.7%)
Age
30-39 20 (0.4%) 51 (0.3%)
40-49 357 (6.3%) 1063 (6.3%)
50-59 1488 (26.4%) 4463 (26.4%)
60-69 1929 (34.2%) 5786 (34.3%)
70-79 1842 (32.7%) 5527 (32.7%)
ECI
Mean ± SD 4.84 ± 3.23 4.84 ± 3.22
Tobacco use
Yes 1090 (19.3%) 3259 (19.3%)
No 4546 (80.7%) 13,631 (80.7%)
Obesity
Yes 1574 (27.9%) 4711 (27.9%)
No 4062 (72.1%) 12,179 (72.1%)
Service location
Hospital inpatient 3442 (61.1%) 16,307 (96.5%)
Hospital outpatient 2194 (38.9%) 583 (3.5%)
ECI, Elixhauser comorbidity index.
Table 2
Association of UKA compared to TKA with infection.
UKA, N ¼ 5636 TKA, N ¼ 16,890
PJI in 90 d
N (%) 15 (0.27%) 79 (0.47%)
RR (95% C.I.) 0.57 (0.33-0.99) 0.00 (Ref)
PJI in 1 y
N (%) 30 (0.53%) 136 (0.81%)
RR (95% C.I.) 0.66 (0.45-0.98) 0.00 (Ref)
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significantly reduced perioperative complications, length of stay,
and rate of readmission. While not a major outcomemeasure, they
did also find that the incidence of PJI in UKA was significantly
lower than that in TKA (HR ¼ 0.5, P < .001) and accounted for just
~5% of all revision UKAs compared with 25% of all revision TKAs
[18]. In an unmatched observational cohort study of 679,010 knee
arthroplasties from the England and Wales registry, Poisson and
piecewise exponential multilevel regression models used to
analyze several risk factors for PJI; cemented UKA also conferred a
lower rate of PJI (RR ¼ 0.5) compared to cemented TKA [23].
Finally, in an older study of roughly 5000 knee arthroplasties in
the Norwegian registry performed between 1994 and 2004, the
overall risk of revision was 2-fold higher for UKA than that for
TKA, but UKAs were associated with a lower (RR ¼ 0.28, P ¼ .01)
risk of PJI than TKA [31]. The results of these registry-based studies
are similar to those of the present study, in which UKA conferred a
lower risk of PJI in a matched patient cohort at 90 days and 1 year.
As expected, most UKA PJIs in the present study within 90 days
were treated with a DAIR (67%), while 60% of UKA PJIs treated
beyond 90 days were treated with a DAIR. Recent studies have
shown that DAIR has equally poor, if not worse, outcomes for UKA
than for TKA, even in relatively young and healthy patient pop-
ulations. In the largest study on UKA PJI treatment outcomes, DAIR
for acute postoperative PJI had a survivorship free from all-cause
reoperation of 55% at 2 years, including a 31% failure for PJI [25].
Similarly, Hernandez et al. [26] reported that 6 of 11 (55%) patients
with UKA PJI treated with DAIR underwent septic (n ¼ 4) or
aseptic (m ¼ 2) reoperation by 5 years. In comparison, Weston
et al [32] reported a 33% rate of reinfection within 5 years in pa-
tients with acute postoperative TKA PJIs treated with DAIR. As
such, while UKA may be associated with slightly lower rates of
deep PJI, the outcomes of PJI treatment do not appear to be su-
perior to those of TKA; however, there is a paucity of data on their
outcomes.
We acknowledge several limitations to the present study. First, it
is a large database study with inherent limitations and biases.
However, given the lower incidence of UKA and even lower inci-
dence of UKA PJI, with less than 50 UKA PJIs specifically analyzed in
the literature [25,26], a large database study is likely the most
resource-efficient method to address this question. Furthermore,
while databases rely on accurate coding of procedures and di-
agnoses, the main goal of this study was to compare UKA and TKA
PJI, so the potential of PJI being miscoded should not bias this as-
sociation differently in one group more than the other. Further-
more, it is possible despite matching on several key demographics
that the study populations were not equivalent and that patient
selection bias on other nonmatched factors may have occurred.
Finally, we did not analyze risk factors for UKA PJI as the overall
number of patients who developed a UKA PJI, even in this large
database sample, was low.
Conclusions
In this large non-Medicare population study of rigorously
matched cohorts of patients undergoing either UKA or TKA, UKA
conferred a significantly lower risk of PJI at 90 days (RR ¼ 0.57) and
1 year (RR¼ 0.66) than TKA. However, the overall incidence of PJI in
both UKA and TKA patients at 90 days and 1 year was overall low at
<1%. As such, surgeons should continue to balance the short-term
benefits and lower perioperative complications of UKA for pa-
tients compared to the improved long-term durability of TKAwhen
counseling patients on knee arthroplasty options.
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Total knee arthroplasty CPT-27447
Periprosthetic joint infection ICD-9-D-99669, ICD-10-D-T8450XA, ICD-10-D-T8450XD, ICD-10-D-T8450XS, ICD-10-D-T8459XA, ICD-10-
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Explantation CPT-27486, CPT-27487, CPT-27488, ICD-9-P-0080, ICD-9-P-0081, ICD-9-P-0082, ICD-9-P-0083, ICD-9-P-
8006, ICD-9-P-8155, ICD-10-P-0SPC0JC, ICD-10-P-0SPC0JZ, ICD-10-P-0SPD0JC, ICD-10-P-0SPD0JZ, ICD-10-
P-0SPT0JZ, ICD-10-P-0SPU0JZ, ICD-10-P-0SPV0JZ, ICD-10-P-0SPW0JZ, ICD-10-P-0SWC0JC, ICD-10-P-
0SWC0JZ, ICD-10-P-0SWD0JC, ICD-10-P-0SWD0JZ, ICD-10-P-0SWT0JZ, ICD-10-P-0SWU0JZ, ICD-10-P-
0SWV0JZ, ICD-10-P-0SWW0JZ
Debridement, antibiotics, and implant retention CPT-27486, CPT-27487, CPT-27488, ICD-9-P-0080, ICD-9-P-0081, ICD-9-P-0082, ICD-9-P-0083, ICD-9-P-
8006, ICD-9-P-8155, ICD-10-P-0SPC0JC, ICD-10-P-0SPC0JZ, ICD-10-P-0SPD0JC, ICD-10-P-0SPD0JZ, ICD-10-
P-0SPT0JZ, ICD-10-P-0SPU0JZ, ICD-10-P-0SPV0JZ, ICD-10-P-0SPW0JZ, ICD-10-P-0SWC0JC, ICD-10-P-
0SWC0JZ, ICD-10-P-0SWD0JC, ICD-10-P-0SWD0JZ, ICD-10-P-0SWT0JZ, ICD-10-P-0SWU0JZ, ICD-10-P-
0SWV0JZ, ICD-10-P-0SWW0JZ
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